Aier Eye Hospital Group allocates up to 1.5 bn yuan for cash management

Aier Eye Hospital Group Co., Ltd. announced on November 14, 2025, its plan for cash management using idle self-owned funds. Following resolutions passed on March 24, 2025, the company will invest up to 1.5 bn yuan in secure, liquid, and low-risk wealth management products for a 12-month period, with funds available for rolling use.

As part of this initiative, the company recently purchased the "Qiyuan Enhanced 360-Day Holding No. 1 A" wealth management product with a subscription of 300m yuan. This RMB-denominated product carries a low to medium risk rating, with a performance benchmark ranging from 2.20% to 3.90%. The interest calculation period for this product is from November 13, 2025, to November 10, 2026. The funds originate from the company’s own capital, and there are no associated party relationships with Ping An Bank Co., Ltd.

The company's strategy aims to improve capital utilization and generate investment returns for the company and its shareholders, while ensuring the safety of funds and avoiding disruption to daily operations. Risk control measures include strict adherence to prudent investment principles, continuous monitoring of product performance, internal audits, and oversight by the supervisory board and independent directors.